Brief: Innovate Biopharmaceuticals Entered Letter Agreement With RDD Pharma To Waive Certain Terms Of Merger Agreement
Jan 22 (Reuters) - Innovate Biopharmaceuticals Inc INNT.O :
* INNOVATE BIOPHARMACEUTICALS - ENTERED LETTER AGREEMENT
WITH RDD
PHARMA, ORBIMED ISRAEL PARTNERS TO WAIVE CERTAIN TERMS OF MERGER
AGREEMENT
Source (https://bit.ly/30MExPW)
Further company coverage: INNT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on 9 Meters Biopharma
See all newsIllumina cuts annual profit forecast as biotech funding woes linger (updated)
Illumina cuts annual profit forecast
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
9 Meters Biopharma falls after filing for bankruptcy protection